The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback